Choosing the right memory T cell for HIV.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19265821.
- Also identified by DOI 10.1038/nm0309-244 and PMC identifier 2669705.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An experimental simian immunodeficiency virus vaccine boosts production of memory T cells at the site where the virus first contacts the body—in the mucosa (293–299). The approach has the potential to result in more effective HIV vaccines than those currently under development.
Medical subject headings
- HIV
- Immunologic Memory
- Simian Immunodeficiency Virus
- T-Lymphocytes
- Viral Vaccines